Jake: Pardon my French, but you’re being a douchebaguette.
my hand: -pouring something-
me: hoe don't do it
my hand: -starts to shake-
me: oh my god
Inexplicable
I just realised Declan Lynch and Justin Russo from Wizards of Waverly Place give me the same vibe
I love how it’s “The Strange Case of Doctor Jekyll and MISTER Hyde” as in, yeah, they are basically two sides of the same person but only ONE has a doctorate
Kaz “Dirtyhands” Brekker: no-nonsense, runs the Crow Club, leader of the Dregs Also Kaz Brekker: “I’ll get the goat.”
more media should be like nimona. there's queens and knights and holograms and flying cars. Why? Because it's cool. Is there an in-universe explanation for any of it? Not really. sometimes world building can be the what without the why or the how and that is cool
nico: I spy with my little eye someone who needs to shut the hell up
Percy: is it me?
nico: it’s always you
Kaz: idk maybe I’m just a bad person
Inej:
Kaz: this is where you say “no kaz, you are a great person, we love you,”
Inej:
Inej: but you aren’t ?!?
Kaz: then fuckin lie
Updated at 4:05 p.m. ET
For the first time, doctors in the U.S. have used the powerful gene-editing technique CRISPR to try to treat a patient with a genetic disorder.
“It is just amazing how far things have come,” says Victoria Gray, 34, of Forest, Miss. “It is wonderful,” she told NPR in an exclusive interview after undergoing the landmark treatment for sickle cell disease.
Gray is the first patient ever to be publicly identified as being involved in a study testing the use of CRISPR for a genetic disease.
“I always had hoped that something will come along,” she says from a hospital bed at the Sarah Cannon Research Institute in Nashville, Tenn., where she received an infusion of billions of genetically modified cells. “It’s a good time to get healed.”
But it probably will take months, if not years, of careful monitoring of Gray and other patients before doctors know whether the treatment is safe and how well it might be helping patients.
Photos: Meredith Rizzo/NPR
Here’s plasmid!